Pelagos Insurance Capital Limit (PLGO) Earnings Analysis
Pelagos Insurance Capital Limit (PLGO) next reports earnings on 2026-08-12, consensus EPS 0.88 USD. Last quarter (2026-02-25) it beat with EPS 1.09 USD vs 1.06 USD est (+2.8%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 6.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PLGO next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | 0.88 USD |
| Revenue estimate | 0.79B |
PLGO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | 1.09 USD | 1.06 USD | +2.8% | Beat |
| 2025-11-12 | 1.21 USD | 1.19 USD | +1.7% | Beat |
| 2025-08-13 | 0.12 USD | -0.38669 USD | +131% | Beat |
| 2025-05-14 | -0.41 USD | -0.46647 USD | +12.1% | Beat |
| 2024-08-14 | 0.54 USD | 0.688 USD | -21.5% | Miss |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
PLGO valuation and analyst view
| Trailing P/E | 6.68 |
|---|---|
| Trailing EPS | 4.045 USD |
| Price / book | 1.04 |
| Dividend yield | 2.38% |
| Market cap | 2.15B |
| Analyst consensus | Buy (3 buy / 2 hold / 2 sell) |
| Avg price target | 24.3 USD |
Related research pages
Frequently asked questions
When is Pelagos Insurance Capital Limit (PLGO)'s next earnings date?
Pelagos Insurance Capital Limit is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 0.88 USD and revenue estimate of 0.79B.
Did PLGO beat earnings last quarter?
In its 2026-02-25 report, PLGO posted EPS of 1.09 USD versus a 1.06 USD estimate — a beat of 2.8%.
What is PLGO's earnings track record?
Over the last 5 reported quarters with consensus data, PLGO beat estimates 4 times (80%).
What is PLGO's current P/E ratio and EPS?
PLGO trades at a trailing P/E of 6.68 on trailing EPS of 4.0447067895771305 USD.
What do analysts rate PLGO?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 3 buy, 2 hold, 2 sell, 0 strong sell). Average 12-month price target: 24.3 USD.